Q2 FY27: revenue up 79%, standalone profit, group loss persists

Revenue Growth 20pctPat Growth 25pctPat NegativeEbitda Margin ExpansionResults View source PDF Explain this filing

OMAXE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.9%Reaction day

₹103.50

prior close

₹103.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Residential Commercial Projects peers, median of 64sector-0.0%-5.8% vs sector

On the reaction day the stock moved 5.8 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.0

10m

-4.5

15m

-4.7

30m

-4.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.9pendingpending-0.0-5.8

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Omaxe's Q2 FY27 consolidated operating revenue rose 79% to Rs 575.51 crore, while net loss narrowed to Rs 25.55 crore from Rs 166.42 crore. Standalone revenue rose 254% to Rs 225.03 crore, with Rs 50.49 crore profit versus a loss. H1 consolidated revenue rose 63% to Rs 981.68 crore and net loss was Rs 24.25 crore. The auditor's overall limited review was clean. SEBI proceedings continue, but management sees no material financial impact.

Likely market impact

Strong sales growth and a standalone profit turnaround help sentiment, but group losses and negative net worth keep shareholder risk high.